Matjaž Sever
Impact in
- Genetics top 2%
- Mesenchymal stem cell research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hematology top 10%
Papers in
- Genetics 26
- Myeloproliferative Neoplasms: Diagnosis and Treatment 16
- Mesenchymal stem cell research 8
- Hematology 13
- Acute Myeloid Leukemia Research 7
- Chronic Myeloid Leukemia Treatments 5
- Co-authors
- Peter Černelč (15 shared papers)Gregor Poglajen (18 shared papers)Bojan Vrtovec (17 shared papers)François Haddad (15 shared papers)Luka Ležaić (8 shared papers)Joseph C. Wu (9 shared papers)Guillermo Torre‐Amione (5 shared papers)Dragoslav Domanović (5 shared papers)
- Journals
- Journal of Cardiac Failure (4 papers)Blood (3 papers)Circulation (2 papers)Leukemia Research (2 papers)Stem Cells Translational Medicine (2 papers)
- Partner nations
- SloveniaUnited StatesGermany
In The Last Decade
Matjaž Sever
47 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 66
- Genetics 395
- Hematology 115
- Surgery 329
- Cardiology and Cardiovascular Medicine 159
- Rheumatology 99
Countries citing papers authored by Matjaž Sever
This map shows the geographic impact of Matjaž Sever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matjaž Sever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matjaž Sever more than expected).
Fields of papers citing papers by Matjaž Sever
This network shows the impact of papers produced by Matjaž Sever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matjaž Sever. The network helps show where Matjaž Sever may publish in the future.
Co-authors
The 25 scholars most cited alongside Matjaž Sever, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 207 | |
| 2 | 2013 | 144 | |
| 3 | 2009 | 119 | |
| 4 | 2010 | 86 | |
| 5 | 2014 | 44 | |
| 6 | 2014 | 44 | |
| 7 | 2016 | 30 | |
| 8 | 2018 | 28 | |
| 9 | 2020 | 28 | |
| 10 | 2014 | 23 | |
| 11 | 2022 | 21 | |
| 12 | 2013 | 20 | |
| 13 | 2017 | 19 | |
| 14 | 2013 | 17 | |
| 15 | 2020 | 14 | |
| 16 | 2015 | 14 | |
| 17 | 2019 | 13 | |
| 18 | 2022 | 13 | |
| 19 | 2001 | 12 | |
| 20 | 2018 | 11 |
About Matjaž Sever
Matjaž Sever is a scholar working on Genetics, Hematology, Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery, having authored 54 papers that have together received 1.1k indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (16 papers), Mesenchymal stem cell research (8 papers), Eosinophilic Disorders and Syndromes (7 papers), Acute Myeloid Leukemia Research (7 papers), Kruppel-like factors research (6 papers), Chronic Myeloid Leukemia Treatments (5 papers), Mast cells and histamine (4 papers) and Tissue Engineering and Regenerative Medicine (3 papers). The work is most often cited by research in Genetics (395 citations), Hematology (115 citations), Surgery (329 citations), Cardiology and Cardiovascular Medicine (159 citations) and Rheumatology (99 citations). Matjaž Sever has collaborated with scholars based in Slovenia, United States and Germany. Frequent co-authors include Peter Černelč, Gregor Poglajen, Bojan Vrtovec, François Haddad, Luka Ležaić, Joseph C. Wu, Guillermo Torre‐Amione, Dragoslav Domanović, Aljaž Sočan and Srđan Verstovšek. Their work appears in journals such as Journal of Cardiac Failure, Blood, Circulation, Leukemia Research and Stem Cells Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.